NEWS: Infermedica named to the 2022 CB Insights’ Digital Health 150 List
Diamond illustration
Piotr Orzechowski
Founder and CEO
Founder & CEO, carrying our vision of making healthcare accessible, affordable, and convenient for everyone on the Planet. In his free time loves playing tennis and guitars.
Infermedica raises $30 M in Series B funding

Infermedica raises $30 M in Series B funding

We’re proud to announce another landmark occasion that enables Infermedica’s growth on a mission for better healthcare.

Infermedica 2021: Year in Review

Infermedica 2021: Year in Review

A roundup of what we’ve accomplished in 2021, and what’s to come next year from Infermedica’s CEO, Piotr Orzechowski.

Infermedica 2020: Year in review

Infermedica 2020: Year in review

Infermedica navigated through 2020 and despite all obstacles, we kept supporting global healthcare to bring better health services. See what we achieved.

Infermedica closes Series A funding with $10.25M

Infermedica closes Series A funding with $10.25M

We are entering the next stage of growth. See how the new funds will accelerate the development of our AI-based solutions for healthcare.

COVID-19 Risk Assessment tool is here

COVID-19 Risk Assessment tool is here

As the pandemic emerged, our team worked non-stop and released a free COVID-19 risk evaluation tool.

Infermedica 2019: Year in Review

Infermedica 2019: Year in Review

2019 was a breakthrough. We've managed to grow our team, gain new clients, improve the product, and raise additional funding.

COVID-19 is a global emergency requiring the entire world community’s focus and commitment to contain and eventually lessen its impact on public health and economies.

COVID-19 and Infermedica

COVID-19 is a global emergency requiring the entire world community’s focus and commitment to contain and eventually lessen its impact on public health and economies.

Infermedica raises $3.65M in a new round of funding

Infermedica raises $3.65M in a new round of funding

Our initial idea has turned into a bold mission to guide every patient to the best possible care, gaining new allies along the way.

Infermedica 2018: Year in Review

Infermedica 2018: Year in Review

With the new year upon us, I’d like to give you an update on 2018 activity and what to expect in 2019.

We’ve moved Symptomate to the next level

We’ve moved Symptomate to the next level

Infermedica’s CEO commends his team’s excellence and reveals enhancements to Symptomate.

Infermedica 2017: Year in review

Infermedica 2017: Year in review

Over three million diagnostic interviews conducted with patients. Amongst other changes at Infermedica in 2017.